Cargando…

Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third-Line Chemotherapy

There are few reports of conversion surgery (CS) after nivolumab monotherapy because it is considered as a third-line standard chemotherapy for unresectable or recurrent gastric cancer. Here, we report a rare case of stage IV gastric cancer effectively treated with CS after nivolumab monotherapy as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Hayato, Fujikawa, Hirohito, Komori, Keisuke, Kano, Kazuki, Takahashi, Kosuke, Yamada, Takanobu, Inokuchi, Yasuhiro, Machida, Nozomu, Yokose, Tomoyuki, Rino, Yasushi, Masuda, Munetaka, Ogata, Takashi, Oshima, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Single Case
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454226/ https://www.ncbi.nlm.nih.gov/pubmed/34616257 http://dx.doi.org/10.1159/000514396

Ejemplares similares

Feasibility of gastric endoscopic submucosal dissection in elderly patients aged ≥ 80 years
por: Inokuchi, Yasuhiro, et al.
Publicado: (2022)

The Glasgow Prognostic Score Before Curative Resection May Predict Postoperative Complications in Patients with Gastric Cancer
por: Shimoda, Yota, et al.
Publicado: (2021)

Phase I/II clinical trial of nivolumab in combination with oligo-fractionated irradiation for unresectable advanced or recurrent gastric cancer
por: Mimura, Kosaku, et al.
Publicado: (2023)

Assessment of the use of computed tomography colonography in early detection of peritoneal metastasis in patients with gastric cancer: A prospective cohort study
por: Iwasaki, Kenichi, et al.
Publicado: (2022)

Prediction of postoperative inflammatory complications after esophageal cancer surgery based on early changes in the C-reactive protein level in patients who received perioperative steroid therapy and enhanced recovery after surgery care: a retrospective analysis
por: Kano, Kazuki, et al.
Publicado: (2017)

The postoperative lean body mass loss at one month leads to a poor survival in patients with locally advanced gastric cancer
por: Aoyama, Toru, et al.
Publicado: (2019)

Clinical Effect of the C-Reactive Protein to Serum Albumin Ratio in Patients with Metastatic Gastric or Gastroesophageal Junction Cancer Treated with Trifluridine/Tipiracil
por: Hashimoto, Itaru, et al.
Publicado: (2023)

Impact of the Age-adjusted Charlson comorbidity index on the short- and long-term outcomes of patients undergoing curative gastrectomy for gastric cancer
por: Maezawa, Yukio, et al.
Publicado: (2019)

Methylene blue-assisted technique for harvesting lymph nodes after radical surgery for gastric cancer: a prospective randomized phase III study
por: Aoyama, Toru, et al.
Publicado: (2014)

The Comparison of the Dietary Intake Loss Between Elderly and Non-Elderly Patients After Gastrectomy for Gastric Cancer
por: Nakazono, Masato, et al.
Publicado: (2022)

Primary Duodenal Carcinoma with Embryonal Carcinoma Features in a Young Man
por: Yamamoto, Naoto, et al.
Publicado: (2021)

A Methylene Blue–assisted Technique for Harvesting Lymph Nodes After Radical Surgery for Gastric Cancer: A Prospective, Randomized, Controlled Study
por: Aoyama, Toru, et al.
Publicado: (2015)

Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab
por: Omata, Wataru, et al.
Publicado: (2022)

Risk factors analysis and stratification for microscopically positive resection margin in gastric cancer patients
por: Kumazu, Yuta, et al.
Publicado: (2020)

Phase II Study of S-1 Monotherapy as a First-line, Combination Therapy of S-1 plus Cisplatin as a Second-line, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: Phase II Study of S-1, S-1 plus Cisplatin, and Weekly Paclitaxel in Patients with Advanced Gastric Carcinoma
por: Rino, Yasushi, et al.
Publicado: (2008)

Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
por: Oro-Ayude, Marcos, et al.
Publicado: (2020)

Nivolumab-Induced de novo Discoid Lupus Erythematosus
por: Manjunath, Jaya, et al.
Publicado: (2022)

A Phase II Study of S-1 Monotherapy as a First-line Combination Therapy of S-1 Plus Cisplatin as a Second-line Therapy, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: A Second Report
por: Rino, Yasushi, et al.
Publicado: (2010)

Feasibility of enhanced recovery after surgery in gastric surgery: a retrospective study
por: Yamada, Takanobu, et al.
Publicado: (2014)

Clinical Significance of the Prealbumin Level in Gastric Cancer Patients Who Receive Curative Treatment
por: Aoyama, Toru, et al.
Publicado: (2021)

Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions
por: Inari, Hitoshi, et al.
Publicado: (2017)

Development of Nivolumab/Ipilimumab-Associated Autoimmune Nephritis during Steroid Therapy
por: Gebauer, Ellen, et al.
Publicado: (2021)

Biomarker analysis to predict the pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer: An exploratory biomarker study of COMPASS, a randomized phase II trial
por: Oshima, Takashi, et al.
Publicado: (2020)

High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1
por: Maezawa, Yukio, et al.
Publicado: (2019)

Efficacy of Plasmapheresis in Nivolumab-Associated ANCA Glomerulonephritis: A Case Report and Pathophysiology Discussion
por: Laamech, Reda, et al.
Publicado: (2021)

Short-term results of a phase II study of preoperative docetaxel/cisplatin/S-1 therapy for locally advanced gastric cancer
por: Tsuchida, Kazuhito, et al.
Publicado: (2020)

Diffuse alveolar hemorrhage with nivolumab monotherapy
por: Shannon, Vickie R., et al.
Publicado: (2020)

Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
por: Potluri, Ravi, et al.
Publicado: (2019)

Clinical Effects of the Neutrophil-to-Lymphocyte Ratio/Serum Albumin Ratio in Patients with Gastric Cancer after Gastrectomy
por: Onuma, Shizune, et al.
Publicado: (2023)

Incidentally Detected Amyloid Light-Chain Amyloidosis Caused by Monoclonal Gammopathy of Undetermined Significance: Possible Time-Dependent Change in Colonic Findings
por: Fukui, Toshiro, et al.
Publicado: (2018)

Type 1 Autoimmune Pancreatitis with Imaging Appearance Similar to That of Malignant Cystic Tumor
por: Ezaki, Takeshi, et al.
Publicado: (2019)

Evaluation of short-term outcomes of laparoscopic-assisted surgery for colorectal cancer in elderly patients aged over 75 years old: a multi-institutional study (YSURG1401)
por: Kazama, Keisuke, et al.
Publicado: (2017)

Identification of a Biomarker Combination for Survival Stratification in pStage II/III Gastric Cancer after Curative Resection
por: Hashimoto, Itaru, et al.
Publicado: (2022)

Acute Appendicitis Caused by Previous Endoscopic Submucosal Dissection for an Adenoma Adjacent to the Appendiceal Orifice
por: Kato, Ryo, et al.
Publicado: (2017)

Chylorrhea following laparoscopy assisted distal gastrectomy with D1+ dissection for early gastric cancer: A case report()
por: Yamada, Takanobu, et al.
Publicado: (2013)

Primary placement technique of jejunostomy using the entristar™ skin-level gastrostomy tube in patients with esophageal cancer
por: Rino, Yasushi, et al.
Publicado: (2011)

Visualization of blood supply route to the reconstructed stomach by indocyanine green fluorescence imaging during esophagectomy
por: Rino, Yasushi, et al.
Publicado: (2014)

Phase II study on the combination of irinotecan plus cisplatin as a second-line therapy in patients with advanced or recurrent gastric cancer
por: RINO, YASUSHI, et al.
Publicado: (2013)

Using NU-KNIT® for hemostasis around recurrent laryngeal nerve during transthoracic esophagectomy with lymphadenectomy for esophageal cancer
por: Rino, Yasushi, et al.
Publicado: (2014)

Signet-ring Cell Carcinoma Component as an Indicator of Anaplastic Lymphoma Kinase Mutations in Colorectal Cancer
por: Nukada, Suguru, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7au9kef3fnbmjhvnqs9f19glqs